Link
Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19
Organization: Public Health Agency of Canada (PHAC)Published: 2024
Image
On January 12, 2024, the Public Health Agency of Canada (PHAC) released the National Advisory Committee on Immunization's (NACI) Guidance on an additional dose of COVID-19 vaccines in the spring of 2024 for individuals at high risk of severe illness due to COVID-19. This guidance is based on current evidence and NACI expert opinion.
Resource Group:
Implementation Tool
Product Type: Guide
Clinics
Vaccine Preventable Diseases
COVID-19
Vaccine Safety and Development
Sub Topics: Vaccine Safety and Development
Vaccine Effectiveness and Efficacy
Product Type: Guide
Category:
Program Planning and Delivery,Clinics,Vaccine Preventable Diseases,COVID-19,Vaccine Safety and Development,Sub Topics: Vaccine Safety and Development,Vaccine Effectiveness and Efficacy Program Planning and DeliveryClinics
Vaccine Preventable Diseases
COVID-19
Vaccine Safety and Development
Sub Topics: Vaccine Safety and Development
Vaccine Effectiveness and Efficacy
Region:
National
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.